Tag Archives | Felix J. Baker

Genomic Health: Proxy Score 60

Genomic HealthGenomic Health, Inc. (NASD:GHDX), one of the stocks in my portfolio, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Their annual meeting is coming up on 6/11/2015. ProxyDemocracy.org had the vote of one fund when I checked and voted on 6/9/2015. I also included CalSTRS vote in the table below.  I voted with management 60% of the time and assigned Genomic Health a proxy score of 60. Continue Reading →

Continue Reading ·

Powered by WordPress. Designed by WooThemes